Exosens Statistics
Total Valuation
Exosens has a market cap or net worth of EUR 1.72 billion. The enterprise value is 1.83 billion.
Market Cap | 1.72B |
Enterprise Value | 1.83B |
Important Dates
The last earnings date was Monday, March 3, 2025.
Earnings Date | Mar 3, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Exosens has 50.78 million shares outstanding.
Current Share Class | n/a |
Shares Outstanding | 50.78M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 25.72% |
Float | 27.50M |
Valuation Ratios
The trailing PE ratio is 55.96 and the forward PE ratio is 22.83.
PE Ratio | 55.96 |
Forward PE | 22.83 |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 94.39 |
P/FCF Ratio | 31.29 |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 16.63, with an EV/FCF ratio of 33.32.
EV / Earnings | 59.58 |
EV / Sales | 4.64 |
EV / EBITDA | 16.63 |
EV / EBIT | 25.02 |
EV / FCF | 33.32 |
Financial Position
The company has a current ratio of 2.94, with a Debt / Equity ratio of 0.63.
Current Ratio | 2.94 |
Quick Ratio | 2.07 |
Debt / Equity | 0.63 |
Debt / EBITDA | 2.38 |
Debt / FCF | 4.76 |
Interest Coverage | 2.34 |
Financial Efficiency
Return on equity (ROE) is 9.96% and return on invested capital (ROIC) is 7.64%.
Return on Equity (ROE) | 9.96% |
Return on Assets (ROA) | 6.20% |
Return on Invested Capital (ROIC) | 7.64% |
Return on Capital Employed (ROCE) | 10.30% |
Revenue Per Employee | 231,824 |
Profits Per Employee | 18,059 |
Employee Count | 1,700 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.96 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
Beta (5Y) | n/a |
52-Week Price Change | n/a |
50-Day Moving Average | 27.13 |
200-Day Moving Average | 21.84 |
Relative Strength Index (RSI) | 63.15 |
Average Volume (20 Days) | 182,655 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Exosens had revenue of EUR 394.10 million and earned 30.70 million in profits.
Revenue | 394.10M |
Gross Profit | 225.60M |
Operating Income | 73.10M |
Pretax Income | 41.80M |
Net Income | 30.70M |
EBITDA | 110.00M |
EBIT | 73.10M |
Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 150.20 million in cash and 261.30 million in debt, giving a net cash position of -111.10 million or -2.19 per share.
Cash & Cash Equivalents | 150.20M |
Total Debt | 261.30M |
Net Cash | -111.10M |
Net Cash Per Share | -2.19 |
Equity (Book Value) | 412.60M |
Book Value Per Share | n/a |
Working Capital | 207.20M |
Cash Flow
In the last 12 months, operating cash flow was 96.20 million and capital expenditures -41.30 million, giving a free cash flow of 54.90 million.
Operating Cash Flow | 96.20M |
Capital Expenditures | -41.30M |
Free Cash Flow | 54.90M |
FCF Per Share | 1.08 |
Margins
Gross margin is 57.24%, with operating and profit margins of 18.55% and 7.79%.
Gross Margin | 57.24% |
Operating Margin | 18.55% |
Pretax Margin | 10.61% |
Profit Margin | 7.79% |
EBITDA Margin | 27.91% |
EBIT Margin | 18.55% |
FCF Margin | 13.93% |
Dividends & Yields
This stock pays an annual dividend of 0.10, which amounts to a dividend yield of 0.30%.
Dividend Per Share | 0.10 |
Dividend Yield | 0.30% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | 0.30% |
Earnings Yield | 1.79% |
FCF Yield | 3.20% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |